190 related articles for article (PubMed ID: 12165480)
1. HPV innate immunity.
Woodworth CD
Front Biosci; 2002 Oct; 7():d2058-71. PubMed ID: 12165480
[TBL] [Abstract][Full Text] [Related]
2. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
Sasagawa T; Takagi H; Makinoda S
J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
[TBL] [Abstract][Full Text] [Related]
3. Evasion of host immune defenses by human papillomavirus.
Westrich JA; Warren CJ; Pyeon D
Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
[TBL] [Abstract][Full Text] [Related]
4. Control of interferon signaling in human papillomavirus infection.
Koromilas AE; Li S; Matlashewski G
Cytokine Growth Factor Rev; 2001; 12(2-3):157-70. PubMed ID: 11325599
[TBL] [Abstract][Full Text] [Related]
5. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
[TBL] [Abstract][Full Text] [Related]
6. [Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].
Mora-García ML; Monroy-García A
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S206-11. PubMed ID: 26462518
[TBL] [Abstract][Full Text] [Related]
7. The role of the immune system in anogenital human papillomavirus.
Frazer IH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
[TBL] [Abstract][Full Text] [Related]
8. High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects.
Lo Cigno I; Calati F; Girone C; Catozzo M; Gariglio M
J Med Virol; 2024 Jun; 96(6):e29685. PubMed ID: 38783790
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.
Raikhy G; Woodby BL; Scott ML; Shin G; Myers JE; Scott RS; Bodily JM
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292244
[TBL] [Abstract][Full Text] [Related]
10. Immunity to oncogenic human papillomaviruses.
Konya J; Dillner J
Adv Cancer Res; 2001; 82():205-38. PubMed ID: 11447764
[TBL] [Abstract][Full Text] [Related]
11. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.
Amador-Molina A; Hernández-Valencia JF; Lamoyi E; Contreras-Paredes A; Lizano M
Viruses; 2013 Oct; 5(11):2624-42. PubMed ID: 24169630
[TBL] [Abstract][Full Text] [Related]
12. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
13. HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.
Van den Bergh JM; Guerti K; Willemen Y; Lion E; Cools N; Goossens H; Vorsters A; Van Tendeloo VF; Anguille S; Van Damme P; Smits EL
J Cell Mol Med; 2014 Jul; 18(7):1372-80. PubMed ID: 24979331
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity and HPV: friends or foes.
Nunes RAL; Morale MG; Silva GÁF; Villa LL; Termini L
Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e549s. PubMed ID: 30328949
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
[TBL] [Abstract][Full Text] [Related]
18. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of the innate immune response by human papillomaviruses.
Hong S; Laimins LA
Virus Res; 2017 Mar; 231():34-40. PubMed ID: 27826042
[TBL] [Abstract][Full Text] [Related]
20. Immune cellular response to HPV: current concepts.
Gonçalves MA; Donadi EA
Braz J Infect Dis; 2004 Feb; 8(1):1-9. PubMed ID: 15137933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
